|
|
|
Volumn 26, Issue 9, 2012, Pages
|
|
FDA approves aflibercept (Zaltrap) for metastatic colorectal cancer.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFLIBERCEPT;
HYBRID PROTEIN;
ARTICLE;
COLORECTAL TUMOR;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LIVER TUMOR;
METASTASIS;
MULTICENTER STUDY (TOPIC);
PATHOLOGY;
PHASE 3 CLINICAL TRIAL (TOPIC);
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
UNITED STATES;
CLINICAL TRIALS, PHASE III AS TOPIC;
COLORECTAL NEOPLASMS;
DRUG APPROVAL;
HUMANS;
LIVER NEOPLASMS;
MULTICENTER STUDIES AS TOPIC;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECOMBINANT FUSION PROTEINS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84868225968
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|